Chiralpedia

R/S Configuration
Definition: CIP-based descriptors assigning absolute configuration to stereocenters.
Context: Universal language for stereochemical specification in pharma and patents.
Example: S-ibuprofen is the active eutomer.
Related Terms: CIP Rules, Absolute Configuration.
Reference: Cahn–Ingold–Prelog rules (1956/1966).

Racemic Compound
Definition: Racemate that crystallizes as a single racemic crystal containing both enantiomers.
Context: Limits simple preferential crystallization; requires alternative resolution routes.
Example: Racemic mandelic acid (context dependent).
Related Terms: Racemate, Conglomerate.
Reference: Eliel & Wilen (1994).

Racemic Drug

Associated Concept: Chiral Switch

Definition: A pharmaceutical product that contains equal amounts (1:1 ratio) of both enantiomers of a chiral drug, forming a racemic mixture (racemate).
Context: Many chiral drugs were originally developed and marketed as racemates because synthesizing or separating individual enantiomers was technically challenging and costly. However, the two enantiomers in a racemic drug may differ significantly in pharmacological activity, pharmacokinetics, metabolism, toxicity, or side-effect profiles. Advances in chiral synthesis and regulatory requirements have led to the development of several single-enantiomer versions of previously marketed racemic drugs, a process known as a chiral switch.
Example: Ibuprofen is marketed as a racemic drug containing both R- and S-ibuprofen. The S-enantiomer is primarily responsible for the anti-inflammatory activity, while the R-enantiomer undergoes partial metabolic conversion to the active S-form in vivo.
Related Terms: Racemate, Enantiomer, Enantiopure Drug, Chiral Switch, Eutomer, Distomer, Stereoselectivity.
Reference: Ariens, E. J. (1984). "Stereochemistry, a Basis for Sophisticated Nonsense in Pharmacokinetics and Clinical Pharmacology." European Journal of Clinical Pharmacology, 26, 663-668; Smith, S. W. (2009). "Chiral Toxicology: It's the Same Thing... Only Different." Toxicological Sciences, 110(1), 4-30; Nguyen, L. A., He, H., & Pham-Huy, C. (2006). "Chiral Drugs: An Overview." International Journal of Biomedical Science, 2(2), 85-100; International Union of Pure and Applied Chemistry. Compendium of Chemical Terminology (Gold Book) - Definitions of racemate, enantiomer, and chirality-related terms.

Key Distinction

Key Insight: A racemic drug is not necessarily inferior to an enantiopure drug. In some cases, both enantiomers contribute beneficially to therapeutic activity, whereas in others one enantiomer may be inactive or associated with adverse effects. Consequently, the choice between a racemate and a single-enantiomer drug depends on scientific, clinical, and regulatory considerations.

Racemic Mixture (Racemate)

Associated Concept: Scalemic Mixture | Enantiopure

Definition: A 1:1 mixture of enantiomers.
Context: Common synthetic outcome; may require resolution or chiral switching.
Example: Racemic thalidomide.
Related Terms: Conglomerate, Racemic Compound.
Reference: FDA Policy on Stereoisomeric Drugs (1992).

Racemization

Associated Concept: Resolution (Chiral Resolution)

Definition: Conversion of an enantiopure substance to a racemate.
Context: Critical risk for chiral APIs and must be controlled in process/storage.
Example: Base-catalyzed racemization of α-chiral carbonyls.
Related Terms: Enantiomerization, Stereomutation.
Reference: IUPAC Gold Book.

Raman Optical Activity (ROA)
Definition: Difference in Raman scattering for circularly polarized light.
Context: Complementary to VCD; sensitive to conformation of chiral molecules and biomacromolecules.
Example: ROA of proteins to assess secondary structure.
Related Terms: VCD, CD.
Reference: Barron, Molecular Light Scattering (2004).

Re/Si Face
Definition: Descriptors for the two faces of a trigonal (sp²) center.
Context: Used to define enantioface selectivity in additions and reductions.
Example: Hydride attack on the Re face of a ketone.
Related Terms: Prochirality, Pro-R/Pro-S.
Reference: IUPAC Gold Book.

Relative Configuration

Associated Concept: Absolute Configuration

Definition: The spatial relationship between stereocenters within a molecule without reference to absolute R/S.
Context: Useful for assigning diastereomer series in synthesis and NMR analysis.
Example: Erythro vs threo in sugars.
Related Terms: Diastereomer, Absolute Configuration.
Reference: Eliel & Wilen (1994).

Relative Stereochemistry
Definition: The spatial relationship between stereocenters within a molecule without reference to absolute configuration.
Context: Important for describing diastereomers in synthesis and structure elucidation.
Example: Erythro and threo configurations of 2,3-butanediols.
Related Terms: Absolute Configuration; Diastereomer; Enantiomer.
Reference: Eliel & Wilen (1994).

Resolution (Chiral Resolution)

Broader Concept: Chiral Separation

Associated Concept: Asymmetric Synthesis

Definition: Resolution, also referred to as chiral resolution, is the process of separating the individual enantiomers of a racemic mixture to obtain one or both enantiomers in enantioenriched or enantiopure form.
Synonyms: Chiral Resolution; Optical Resolution (historical term); Enantiomeric Resolution.
Context: Resolution is one of the principal strategies for obtaining optically active compounds from racemic mixtures. Unlike asymmetric synthesis, which creates chirality during chemical synthesis, resolution begins with a racemate and separates its constituent enantiomers. Resolution may be achieved by classical methods (e.g., diastereomeric salt formation and fractional crystallization), chromatographic techniques using chiral stationary phases, enzymatic or kinetic resolution, dynamic kinetic resolution, or preferential crystallization. Resolution remains an indispensable technique in pharmaceutical development, agrochemical production, natural product isolation, and analytical chemistry.
Example: The enantiomers of ibuprofen can be resolved by chiral high-performance liquid chromatography (HPLC) using a chiral stationary phase. Alternatively, racemic amines may be resolved by forming diastereomeric salts with a chiral resolving agent, followed by fractional crystallization.
Related Terms: Classical Resolution, Kinetic Resolution, Dynamic Kinetic Resolution, Optical Resolution, Chiral Separation, Racemate, Enantiopure, Enantioenriched, Chiral Chromatography, Asymmetric Synthesis.
Reference: Jacques, J., Collet, A., & Wilen, S. H. (1994). Enantiomers, Racemates, and Resolutions. Krieger Publishing Company, Malabar, Florida. ISBN: 978-0894648282; Ahuja, S. (2000). Chiral Separation Methods for Pharmaceutical and Biotechnological Products. John Wiley & Sons. ISBN: 978-0471370308; Faber, K. (2018). Biotransformations in Organic Chemistry (7th ed.). Springer. ISBN: 978-3319615227; International Union of Pure and Applied Chemistry. Compendium of Chemical Terminology (Gold Book) - Entries on resolution and enantiomer separation.
Key Distinction
Resolution (Chiral Resolution): Separation of the enantiomers of a racemic mixture into individual enantiomers.
Chiral Separation: A broader term encompassing all methods used to separate enantiomers, whether from a racemate or an enantioenriched mixture.
Asymmetric Synthesis: Direct preparation of one enantiomer from achiral or prochiral starting materials using a chiral source.
Racemization: Conversion of an enantiomerically enriched or enantiopure compound into a racemic mixture, thereby reducing or eliminating enantiomeric excess.
Key Insight
Resolution is the classical and preferred stereochemical term for the separation of a racemic mixture into its constituent enantiomers. Since the process inherently involves chiral molecules, the adjective "chiral" is optional; therefore, Resolution and Chiral Resolution are generally regarded as synonymous in stereochemistry. The term Optical Resolution is an older synonym that originated from the historical use of optical rotation to distinguish and isolate enantiomers.